Overcoming Challenges in ER+/HER2- Advanced Breast Cancer Care

Overcoming Challenges in ER+/HER2- Advanced Breast Cancer Care

ReachMD Healthcare Image
RestartResume

Explore key strategies for addressing common challenges in ER+/HER2- advanced breast cancer care, like toxicities, endocrine resistance, and more.

  • Overview

    Endocrine resistance and toxicities are just a few of the many challenges facing clinicians who treat patients with ER+/HER2- advanced breast cancer. So what strategies can we use to better address these challenges and unmet needs? Joining Dr. Jennifer Caudle to share her approach is Dr. Stephanie Graff, Director of the Breast Oncology Program at Lifespan Cancer Institute in Providence, Rhode Island.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free